Manning Anthony M.
CIK 0001716468 Name as filed on the most recent filing
Filed as Manning Anthony M. (38)
45 transaction lines · from 38 filings · filed 2018-11-13 to 2026-06-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
45 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-29 |
Monte Rosa Therapeutics, Inc. GLUE |
S, Open-market sale | 10,000 disposed | 23.11 | 231,100.00 | Form 4, filing 0001193125-26-290484 | |
| 2026-05-21 |
Monte Rosa Therapeutics, Inc. GLUE |
S, Open-market sale | 10,000 disposed | 18.01 | 180,100.00 | Form 4, filing 0001193125-26-236840 | |
| 2020-08-13 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 363 disposed | 29.31 | 10,639.53 | Form 4, filing 0001179110-20-009025 | |
| 2020-08-13 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 40 disposed | 29.34 | 1,173.60 | Form 4, filing 0001179110-20-009025 | |
| 2020-08-10 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 347 disposed | 32.36 | 11,228.92 | Form 4, filing 0001179110-20-008886 | |
| 2020-07-21 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 1,745 disposed | 34.69 | 60,534.05 | Form 4, filing 0001179110-20-008423 | |
| 2020-07-21 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 194 disposed | 34.67 | 6,725.98 | Form 4, filing 0001179110-20-008423 | |
| 2020-07-20 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 49,538 disposed | 33.91 | 1,679,833.58 | Form 4, filing 0001179110-20-008396 | |
| 2020-07-20 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 1,561 disposed | 33.95 | 52,995.95 | Form 4, filing 0001179110-20-008396 | |
| 2020-06-30 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 6,811 disposed | 35.10 | 239,066.10 | Form 4, filing 0001104659-20-080015 | |
| 2020-06-12 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 6,756 disposed | 30.15 | 203,693.40 | Form 4, filing 0001179110-20-007361 | |
| 2020-05-11 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 414 disposed | 33.75 | 13,972.50 | Form 4, filing 0001179110-20-005772 | |
| 2020-05-08 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 336 disposed | 33.30 | 11,188.80 | Form 4, filing 0001179110-20-005718 | |
| 2020-04-21 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 1,886 disposed | 30.55 | 57,617.30 | Form 4, filing 0001179110-20-005044 | |
| 2020-04-20 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 1,614 disposed | 28.96 | 46,741.44 | Form 4, filing 0001179110-20-004998 | |
| 2020-03-06 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 7,310 disposed | 29.00 | 211,990.00 | Form 4, filing 0001179110-20-003312 | |
| 2020-02-18 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 16,459 disposed | 32.56 | 535,905.04 | Form 4, filing 0001179110-20-001974 | |
| 2020-02-13 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 8,541 disposed | 30.03 | 256,486.23 | Form 4, filing 0001179110-20-001668 | |
| 2020-02-12 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 789 disposed | 31.63 | 24,956.07 | Form 4, filing 0001179110-20-001668 | |
| 2020-02-11 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 112 disposed | 32.23 | 3,609.76 | Form 4, filing 0001179110-20-001524 | |
| 2020-02-10 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 224 disposed | 31.50 | 7,056.00 | Form 4, filing 0001179110-20-001467 | |
| 2020-01-22 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 2,038 disposed | 29.01 | 59,122.38 | Form 4, filing 0001179110-20-000760 | |
| 2020-01-22 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 227 disposed | 29.02 | 6,587.54 | Form 4, filing 0001179110-20-000760 | |
| 2020-01-21 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 1,235 disposed | 30.08 | 37,148.80 | Form 4, filing 0001179110-20-000703 | |
| 2020-01-15 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 29,114 disposed | 28.44 | 828,002.16 | Form 4, filing 0001179110-20-000653 | |
| 2019-12-24 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 51,445 disposed | 20.00 | 1,028,900.00 | Form 4, filing 0001179110-19-013163 | |
| 2019-11-13 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 557 disposed | 16.53 | 9,207.21 | Form 4, filing 0001179110-19-011705 | |
| 2019-11-13 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 62 disposed | 16.52 | 1,024.24 | Form 4, filing 0001179110-19-011705 | |
| 2019-11-12 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 169 disposed | 16.18 | 2,734.42 | Form 4, filing 0001179110-19-011658 | |
| 2019-11-08 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 337 disposed | 16.06 | 5,412.22 | Form 4, filing 0001179110-19-011614 | |
| 2019-11-07 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 8,420 disposed | 15.96 | 134,383.20 | Form 4, filing 0001179110-19-011614 | |
| 2019-10-18 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 6,365 disposed | 13.83 | 88,027.95 | Form 4, filing 0001179110-19-011137 | |
| 2019-10-14 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 787 disposed | 13.55 | 10,663.85 | Form 4, filing 0001179110-19-011036 | |
| 2019-08-12 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 114 disposed | 11.64 | 1,326.96 | Form 4, filing 0001179110-19-009461 | |
| 2019-08-08 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 226 disposed | 11.67 | 2,637.42 | Form 4, filing 0001179110-19-009450 | |
| 2019-08-08 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 221 disposed | 11.82 | 2,612.22 | Form 4, filing 0001179110-19-009336 | |
| 2019-06-20 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 39,433 disposed | 13.00 | 512,629.00 | Form 4, filing 0001179110-19-008018 | |
| 2019-05-10 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 114 disposed | 14.00 | 1,596.00 | Form 4, filing 0001179110-19-006037 | |
| 2019-05-08 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 224 disposed | 13.68 | 3,064.32 | Form 4, filing 0001179110-19-005767 | |
| 2019-02-14 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 4,449 disposed | 13.10 | 58,281.90 | Form 4, filing 0001179110-19-002090 | |
| 2019-02-13 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 7,717 disposed | 12.70 | 98,005.90 | Form 4, filing 0001179110-19-001908 | |
| 2019-02-12 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 133 disposed | 12.77 | 1,698.41 | Form 4, filing 0001179110-19-001833 | |
| 2019-02-08 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 264 disposed | 11.52 | 3,041.28 | Form 4, filing 0001179110-19-001701 | |
| 2018-11-12 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 113 disposed | 13.15 | 1,485.95 | Form 4, filing 0001179110-18-012843 | |
| 2018-11-08 |
Momenta Pharmaceuticals Inc MNTA |
S, Open-market sale | 229 disposed | 14.09 | 3,226.61 | Form 4, filing 0001179110-18-012785 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 45
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Manning Anthony M., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001716468
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6